The Fatty Liver Foundation advocates for early screening. Our plan is to deliver liver care screening for the estimated 40 million co-morbid diabetes/NAFLD/NASH patients. This patient group is our initial target for screening because up to 70 percent of type 2 diabetics have undiagnosed liver disease. The project’s long-term goal is to have 400 testing locations seeing one million patients a year.
A recent article about us in Real Wor... - Living with Fatty...
A recent article about us in Real World Health Care
Written by
nash2
Partner
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Latest data on Resmetirom is published, FDA approval is expected in March
Today marks a significant milestone for Madrigal's NASH/MASH program and a major step forward...
Will You Take Our Survey Seeking NAFLD/NASH Patient Voices?
Hi everyone,
My name is Tiffany and I'm joining FLF as a Program Coordinator - I'm so excited to...
NASH: what is reversible?
Hello all,
I recently was diagnosed with nash and i ve been trying to learn as much as possible...
The New NAFLD/NASH guidance is out but how do we use it as patients? Here is an explanation and a suggestion from the Fatty Liver Foundation
The new guidance for managing NAFLD/NASH has been officially published. This is the official...
I need help from a few NAFLD/NASH patients who are willing to tell their stories and perhaps participate in a panel discussion.
I think you probably know that Madrigal is likely to have the first drug approved to treat...
Can some of you comment on weakness with liver disease?
Questions...
Help me understand 
Stoping NASH/ Fatty Liver before Cirrhosis.
